Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Influence of intermittent fasting on myocardial infarction-induced cardiac remodeling.

Okoshi K, Cezar MDM, Polin MAM, Paladino JR Jr, Martinez PF, Oliveira SA Jr, Lima ARR, Damatto RL, Paiva SAR, Zornoff LAM, Okoshi MP.

BMC Cardiovasc Disord. 2019 May 28;19(1):126. doi: 10.1186/s12872-019-1113-4.

3.

Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats.

Shimada T, Yoshiyama M, Takeuchi K, Omura T, Takemoto Y, Kim S, Iwao H, Yoshikawa J.

Cardiovasc Res. 1998 Mar;37(3):618-26.

PMID:
9659445
4.

The role of hypertrophy and growth factors in heart failure.

Ross J Jr, Hongo M.

J Card Fail. 1996 Dec;2(4 Suppl):S121-8.

PMID:
8951569
5.

Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction.

Hongo M, Sentianin EM, Tanaka N, Mao L, McKirnan MD, Clark RG, Won W, Chien KR, Ross J Jr.

J Card Fail. 1998 Sep;4(3):213-24.

PMID:
9754592
6.

p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.

See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.

J Am Coll Cardiol. 2004 Oct 19;44(8):1679-89.

7.

Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats.

Rosa CM, Xavier NP, Henrique Campos D, Fernandes AA, Cezar MD, Martinez PF, Cicogna AC, Gimenes C, Gimenes R, Okoshi MP, Okoshi K.

Cardiovasc Diabetol. 2013 Oct 17;12:152. doi: 10.1186/1475-2840-12-152.

8.

Chronic intermittent fasting improves the survival following large myocardial ischemia by activation of BDNF/VEGF/PI3K signaling pathway.

Katare RG, Kakinuma Y, Arikawa M, Yamasaki F, Sato T.

J Mol Cell Cardiol. 2009 Mar;46(3):405-12. doi: 10.1016/j.yjmcc.2008.10.027. Epub 2008 Nov 12.

PMID:
19059263
9.

Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.

von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H.

Circ Heart Fail. 2015 Jan;8(1):71-8. doi: 10.1161/CIRCHEARTFAILURE.114.001785. Epub 2014 Oct 31.

PMID:
25362207
10.

Left ventricular function and remodeling after myocardial infarction in aging rats.

Raya TE, Gaballa M, Anderson P, Goldman S.

Am J Physiol. 1997 Dec;273(6):H2652-8. doi: 10.1152/ajpheart.1997.273.6.H2652.

PMID:
9435600
11.

Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.

Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.

Hypertens Res. 2007 May;30(5):427-37.

PMID:
17587755
12.

The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.

Castardeli C, Sartório CL, Pimentel EB, Forechi L, Mill JG.

Biomed Pharmacother. 2018 Nov;107:212-218. doi: 10.1016/j.biopha.2018.07.170. Epub 2018 Aug 6.

PMID:
30092400
13.

Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats.

Zornoff LA, Paiva SA, Matsubara BB, Matsubara LS, Spadaro J.

J Cardiovasc Pharmacol Ther. 2000 Jul;5(3):203-9.

PMID:
11150409
14.

Progressive Reduction in Myocyte Autophagy After Myocardial Infarction in Rabbits: Association with Oxidative Stress and Left Ventricular Remodeling.

Chi RF, Wang JP, Wang K, Zhang XL, Zhang YA, Kang YM, Han XB, Li B, Qin FZ, Fan BA.

Cell Physiol Biochem. 2017;44(6):2439-2454. doi: 10.1159/000486167. Epub 2017 Dec 18.

15.
16.

Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction.

González GE, Wilensky L, Cassaglia P, Morales C, Gelpi RJ.

Cardiovasc Pathol. 2016 May-Jun;25(3):208-213. doi: 10.1016/j.carpath.2016.01.004. Epub 2016 Jan 22.

PMID:
26897484
17.

Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.

Takeuchi K, Omura T, Yoshiyama M, Yoshida K, Otsuka R, Shimada Y, Ujino K, Yoshikawa J.

Heart Vessels. 1999;14(3):111-9.

PMID:
10776803
18.

Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor.

Bridgman P, Aronovitz MA, Kakkar R, Oliverio MI, Coffman TM, Rand WM, Konstam MA, Mendelsohn ME, Patten RD.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H586-92. Epub 2005 Mar 11.

19.

Effect of diltiazem on cardiac remodeling in rats assessed by Doppler echocardiography and mRNA expression.

Yoshiyama M, Takeuchi K, Omura T, Izutani S, Nakamura Y, Akioka K, Kim S, Iwao H, Yoshikawa J.

Cardiovasc Drugs Ther. 1999 May;13(3):249-58.

PMID:
10439888
20.

Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling.

Deng L, Huang B, Qin D, Ganguly K, El-Sherif N.

J Cardiovasc Electrophysiol. 2001 Sep;12(9):1055-61.

PMID:
11573696

Supplemental Content

Support Center